CLINICAL TRIALS PROFILE FOR ATROPINE
✉ Email this page to a colleague
All Clinical Trials for ATROPINE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000170 ↗ | Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia | Completed | National Eye Institute (NEI) | Phase 3 | 1999-04-01 | - To determine whether the success rate with drug treatment (atropine) of amblyopia due to strabismus or anisometropia in patients less than 7 years old is equivalent to the success rate with occlusion (patching) therapy - To develop more precise estimates of the success rates of amblyopia treatment - To identify factors that may be associated with successful treatment of amblyopia - To collect data on the course of treated amblyopia to provide more precise estimates of treatment effects than are now available Extended Follow up of Study Patients - Primary: To determine the long-term visual acuity outcome at age 10 years and at age 15 years in patients diagnosed with amblyopia before age 7 years. - Secondary: To determine whether the long-term visual acuity outcome at age 10 years and at age 15 years differs between patients who received patching followed by best clinical care and patients who received atropine followed by best clinical care |
NCT00000170 ↗ | Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia | Completed | Jaeb Center for Health Research | Phase 3 | 1999-04-01 | - To determine whether the success rate with drug treatment (atropine) of amblyopia due to strabismus or anisometropia in patients less than 7 years old is equivalent to the success rate with occlusion (patching) therapy - To develop more precise estimates of the success rates of amblyopia treatment - To identify factors that may be associated with successful treatment of amblyopia - To collect data on the course of treated amblyopia to provide more precise estimates of treatment effects than are now available Extended Follow up of Study Patients - Primary: To determine the long-term visual acuity outcome at age 10 years and at age 15 years in patients diagnosed with amblyopia before age 7 years. - Secondary: To determine whether the long-term visual acuity outcome at age 10 years and at age 15 years differs between patients who received patching followed by best clinical care and patients who received atropine followed by best clinical care |
NCT00000333 ↗ | Evaluation of Benztropine for Cocaine Craving - 2 | Completed | Washington D.C. Veterans Affairs Medical Center | Phase 2 | 2001-05-01 | The purpose of this study is to compare the efficacy of benztropine (or DA reuptake inhibitor) with atropine and placebo in affecting stimulated craving to cocaine cues. |
NCT00000333 ↗ | Evaluation of Benztropine for Cocaine Craving - 2 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 2001-05-01 | The purpose of this study is to compare the efficacy of benztropine (or DA reuptake inhibitor) with atropine and placebo in affecting stimulated craving to cocaine cues. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ATROPINE
Condition Name
Clinical Trial Locations for ATROPINE
Trials by Country
Clinical Trial Progress for ATROPINE
Clinical Trial Phase
Clinical Trial Sponsors for ATROPINE
Sponsor Name